Viewing Study NCT03778957


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2025-12-24 @ 6:31 PM
Study NCT ID: NCT03778957
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-10
First Post: 2018-11-28
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module